Arcadia Biosciences, Inc. (RKDA)
USD 3.2
(7.11%)
USD 3.2
(7.11%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -13.93 Million USD | 43.31% |
| 2022 | -13.64 Million USD | -23.72% |
| 2021 | -23.26 Million USD | 11.81% |
| 2020 | -5.44 Million USD | -1.94% |
| 2019 | -28.67 Million USD | 10.7% |
| 2018 | -13.31 Million USD | -66.32% |
| 2017 | -14.65 Million USD | 23.48% |
| 2016 | -17.97 Million USD | -21.89% |
| 2015 | -14.97 Million USD | 0.32% |
| 2014 | -15.39 Million USD | -45.48% |
| 2013 | -10.17 Million USD | -4.37% |
| 2012 | -9.74 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.79 Million USD | -8.14% |
| 2024 Q2 | -2 Million USD | 33.24% |
| 2023 Q3 | -3.24 Million USD | 60.24% |
| 2023 Q2 | -8.15 Million USD | -99.56% |
| 2023 FY | - USD | 43.31% |
| 2023 Q1 | -4.08 Million USD | 31.27% |
| 2023 Q4 | -3.03 Million USD | 6.45% |
| 2022 Q1 | -4.8 Million USD | 41.55% |
| 2022 Q2 | -5.27 Million USD | -9.78% |
| 2022 Q3 | -6.32 Million USD | -19.83% |
| 2022 FY | - USD | -23.72% |
| 2022 Q4 | -5.94 Million USD | 5.96% |
| 2021 Q3 | -7.18 Million USD | -54.68% |
| 2021 Q1 | 1.69 Million USD | -79.82% |
| 2021 FY | - USD | 11.81% |
| 2021 Q4 | -8.22 Million USD | -14.4% |
| 2021 Q2 | -4.64 Million USD | -374.32% |
| 2020 Q2 | -6.71 Million USD | -18.91% |
| 2020 FY | - USD | -1.94% |
| 2020 Q4 | 8.39 Million USD | 201.57% |
| 2020 Q3 | -8.26 Million USD | -23.13% |
| 2020 Q1 | -5.64 Million USD | -17.41% |
| 2019 FY | - USD | 10.7% |
| 2019 Q3 | -6.35 Million USD | 55.94% |
| 2019 Q4 | -4.8 Million USD | 24.35% |
| 2019 Q1 | 4.31 Million USD | 152.53% |
| 2019 Q2 | -14.42 Million USD | -434.49% |
| 2018 Q1 | -1.88 Million USD | 34.95% |
| 2018 FY | - USD | -66.32% |
| 2018 Q4 | -8.2 Million USD | -108.22% |
| 2018 Q2 | -3.99 Million USD | -111.82% |
| 2018 Q3 | -3.94 Million USD | 1.4% |
| 2017 FY | - USD | 23.48% |
| 2017 Q1 | -3.88 Million USD | 26.7% |
| 2017 Q2 | -3.56 Million USD | 8.09% |
| 2017 Q3 | -3.5 Million USD | 1.91% |
| 2017 Q4 | -2.9 Million USD | 17.11% |
| 2016 Q1 | -4.86 Million USD | -53.36% |
| 2016 FY | - USD | -21.89% |
| 2016 Q4 | -5.29 Million USD | -40.96% |
| 2016 Q3 | -3.75 Million USD | 9.1% |
| 2016 Q2 | -4.13 Million USD | 15.06% |
| 2015 FY | - USD | 0.32% |
| 2015 Q3 | -3.88 Million USD | -9.42% |
| 2015 Q2 | -3.54 Million USD | 29.55% |
| 2015 Q1 | -5.03 Million USD | -229.52% |
| 2015 Q4 | -3.17 Million USD | 18.24% |
| 2014 Q1 | -2.5 Million USD | -15.89% |
| 2014 Q2 | -4.91 Million USD | -95.7% |
| 2014 Q3 | -6.66 Million USD | -35.78% |
| 2014 FY | - USD | -45.48% |
| 2014 Q4 | -1.52 Million USD | 77.08% |
| 2013 FY | - USD | -4.37% |
| 2013 Q4 | -2.16 Million USD | 14.73% |
| 2013 Q3 | -2.53 Million USD | 7.18% |
| 2013 Q1 | -2.73 Million USD | 0.0% |
| 2013 Q2 | -2.73 Million USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Bioceres Crop Solutions Corp. | 54.15 Million USD | 125.738% |
| Muliang Viagoo Technology, Inc. | 467.3 Thousand USD | 3082.66% |
| N2OFF, Inc. | -7.51 Million USD | -85.433% |
| Yield10 Bioscience, Inc. | -14.12 Million USD | 1.338% |